Low incidence of invasive fungal infections in a large observational cohort of patients initiating IL-17 or IL-23 inhibitor therapy, United States, 2016-2022.
J Am Acad Dermatol
; 91(1): 119-122, 2024 Jul.
Article
en En
| MEDLINE
| ID: mdl-38462134
Palabras clave
Candida infection; Crohn's disease; blastomycosis; brodalumab; candidiasis; coccidioidomycosis; esophageal candidiasis; guselkumab; histoplasmosis; inflammatory bowel disease; interleukin-17 inhibitors; interleukin-23 inhibitors; invasive fungal infection; ixekizumab; psoriasis; risankizumab; secukinumab; tildrakizumab; ustekinumab
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Psoriasis
/
Interleucina-17
/
Interleucina-23
/
Infecciones Fúngicas Invasoras
Límite:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
País/Región como asunto:
America do norte
Idioma:
En
Revista:
J Am Acad Dermatol
Año:
2024
Tipo del documento:
Article
Pais de publicación:
Estados Unidos